Pliant Therapeutics Inc (PLRX)

13.75 +0.79  +6.10% NASDAQ Dec 7, 16:00 13.75 0.00  0.00% After-Hours: 20:00 USD

Pliant Therapeutics Free Cash Flow (Quarterly):

-22.99M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -22.99M
June 30, 2021 -20.04M
March 31, 2021 -13.91M
Dec. 31, 2020 -17.07M
Sept. 30, 2020 -16.12M
June 30, 2020 7.486M
March 31, 2020 -13.10M
Dec. 31, 2019 36.56M
Sept. 30, 2019 -14.92M
June 30, 2019 -14.24M
March 31, 2019 -11.10M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Benchmarks

Atara Biotherapeutics Inc -62.83M
Jaguar Health Inc -9.432M
Progenity Inc -43.19M

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -22.99M Sep 2021
Maximum 36.56M Dec 2019
Average -9.042M


Top Premarket Gainers
MT Newswires 09/07 08:09 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.